Files in this item

FilesDescriptionFormat

application/pdf

application/pdfcrispr.2019.0029.pdf (151kB)
(no description provided)PDF

Description

Title:Controlling CRISPR Through Law: Legal Regimes as Precautionary Principles
Author(s):Sherkow, Jacob S.
Subject(s):crispr
precautionary
bioethics
governance
law
Abstract:Since its advent in 2012, CRISPR has spawned a cottage industry of bioethics literature. One principal criticism of the technology is its virtually instant widespread adoption prior to deliberative bodies conducting a meaningful ethical review of its harms and benefits—a violation, to some, of bioethics' “precautionary principle.” This view poorly considers, however, the role that the law can play—and does, in fact, play—in policing the introduction of ethically problematic uses of the technology. This Perspective recounts these legal regimes, including regulatory agencies and premarket approval, tort law and deterrence, patents and ethical licenses, funding agencies and review boards, as well as local politics. Identifying these legal regimes and connecting them to the precautionary principle should be instructive for bioethicists and policy makers who wish to conduct ethical reviews of new applications of CRISPR prior to their introduction.
Issue Date:2019-10-09
Publisher:The CRISPR Journal
Citation Info:Jacob S. Sherkow, Controlling CRISPR Through Law: Legal Regimes as Precautionary Principles, 2 CRISPR J. 299 (2019)
Genre:Journal (whole)
Type:Text
Language:English
URI:http://hdl.handle.net/2142/110349
DOI:10.1089/crispr.2019.0029
Date Available in IDEALS:2021-08-23


This item appears in the following Collection(s)

  • Illinois Research and Scholarship
    This is the default collection for all research and scholarship developed by faculty, staff, or students at the University of Illinois at Urbana-Champaign

Item Statistics